Resmed Inc. buy Mizuho
Start price
13.09.23
/
50%
€137.25
Target price
13.09.24
€167.69
Performance (%)
64.15%
End price
14.09.24
€225.30
Summary
This prediction ended on 14.09.24 with a price of €225.30. With a performance of 64.15% the BUY prediction by Mizuho was a big success. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.82 was paid as dividends for this prediction. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.154% | -2.154% | 2.692% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Mizuho from $255.00 to $180.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten